{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
China Resources Double-Crane Pharmaceutical Co., Ltd.
China Resources Double-Crane Stock Hits Day High with 3.68% Surge
China Resources Double-Crane Pharmaceutical Co., Ltd. experienced a notable increase on July 1, 2026, contrasting with the broader market's modest gain. Despite a recent uptick, the stock has faced challenges over the past year and three years, with a decline in year-to-date performance and a commitment to shareholder returns through dividends.
China Resources Double-Crane Stock Hits Day Low Amid Price Pressure at CNY 16.00
China Resources Double-Crane Pharmaceutical Co., Ltd. faced a significant decline in stock value, reflecting ongoing challenges. The company has underperformed over the past year, with modest net sales growth and low operating cash flow. In contrast, the broader market, represented by the Shanghai Composite index, has shown positive gains.
China Resources Double-Crane Stock Hits Day High with 6.86% Surge
China Resources Double-Crane Pharmaceutical Co., Ltd. saw a notable increase in its stock today, contrasting with the broader market's modest gains. Despite this daily uptick, the company has faced longer-term challenges, including declines in annual and year-to-date performance, alongside a slight profit decrease over the past year.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
